These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 19297595

  • 1. Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli.
    Segonds C, Clavel-Batut P, Thouverez M, Grenet D, Le Coustumier A, Plésiat P, Chabanon G.
    J Clin Microbiol; 2009 May; 47(5):1510-6. PubMed ID: 19297595
    [Abstract] [Full Text] [Related]

  • 2. Major Aspects of Burkholderia gladioli and Burkholderia cepacia Infections in Children.
    Bedir Demirdag T, Ozkaya Parlakay A, Aygar IS, Gulhan B, Kanik Yuksek S.
    Pediatr Infect Dis J; 2020 May; 39(5):374-378. PubMed ID: 32118858
    [Abstract] [Full Text] [Related]

  • 3. Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods.
    van Pelt C, Verduin CM, Goessens WH, Vos MC, Tümmler B, Segonds C, Reubsaet F, Verbrugh H, van Belkum A.
    J Clin Microbiol; 1999 Jul; 37(7):2158-64. PubMed ID: 10364579
    [Abstract] [Full Text] [Related]

  • 4. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli Cystic Fibrosis Isolates.
    Zeiser ET, Becka SA, Wilson BM, Barnes MD, LiPuma JJ, Papp-Wallace KM.
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848
    [Abstract] [Full Text] [Related]

  • 5. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium.
    Revets H, Vandamme P, Van Zeebroeck A, De Boeck K, Struelens MJ, Verhaegen J, Ursi JP, Verschraegen G, Franckx H, Malfroot A, Dab I, Lauwers S.
    Acta Clin Belg; 1996 Aug; 51(4):222-30. PubMed ID: 8858887
    [Abstract] [Full Text] [Related]

  • 6. Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center.
    Kennedy MP, Coakley RD, Donaldson SH, Aris RM, Hohneker K, Wedd JP, Knowles MR, Gilligan PH, Yankaskas JR.
    J Cyst Fibros; 2007 Jul; 6(4):267-73. PubMed ID: 17137846
    [Abstract] [Full Text] [Related]

  • 7. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland.
    Pitt TL, Kaufmann ME, Patel PS, Benge LC, Gaskin S, Livermore DM.
    J Med Microbiol; 1996 Mar; 44(3):203-10. PubMed ID: 8636938
    [Abstract] [Full Text] [Related]

  • 8. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates.
    Segonds C, Heulin T, Marty N, Chabanon G.
    J Clin Microbiol; 1999 Jul; 37(7):2201-8. PubMed ID: 10364586
    [Abstract] [Full Text] [Related]

  • 9. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.
    Henry DA, Campbell ME, LiPuma JJ, Speert DP.
    J Clin Microbiol; 1997 Mar; 35(3):614-9. PubMed ID: 9041399
    [Abstract] [Full Text] [Related]

  • 10. Matrix-assisted laser desorption/ionization time-of-flight MS for the accurate identification of Burkholderia cepacia complex and Burkholderia gladioli in the clinical microbiology laboratory.
    Wong KSK, Dhaliwal S, Bilawka J, Srigley JA, Champagne S, Romney MG, Tilley P, Sadarangani M, Zlosnik JEA, Chilvers MA.
    J Med Microbiol; 2020 Aug; 69(8):1105-1113. PubMed ID: 32597748
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
    Kenna DTD, Lilley D, Coward A, Martin K, Perry C, Pike R, Hill R, Turton JF.
    J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
    [Abstract] [Full Text] [Related]

  • 12. [An opportunistic pathogen frequently isolated from immunocompromised patients: Burkholderia cepacia complex].
    Baylan O.
    Mikrobiyol Bul; 2012 Apr; 46(2):304-18. PubMed ID: 22639321
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification, molecular characterisation and antimicrobial susceptibility of genomovars of the Burkholderia cepacia complex in Spain.
    Medina-Pascual MJ, Valdezate S, Villalón P, Garrido N, Rubio V, Saéz-Nieto JA.
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3385-96. PubMed ID: 22855365
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fatal Burkholderia gladioli infection misidentified as Empedobacter brevis in a lung transplant recipient with cystic fibrosis.
    Brizendine KD, Baddley JW, Pappas PG, Leon KJ, Rodriguez JM.
    Transpl Infect Dis; 2012 Aug; 14(4):E13-8. PubMed ID: 22429703
    [Abstract] [Full Text] [Related]

  • 18. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis.
    St Denis M, Ramotar K, Vandemheen K, Tullis E, Ferris W, Chan F, Lee C, Slinger R, Aaron SD.
    Chest; 2007 Apr; 131(4):1188-96. PubMed ID: 17426227
    [Abstract] [Full Text] [Related]

  • 19. Subspecific differentiation of Burkholderia cepacia isolates in cystic fibrosis.
    Livesley MA, Baxter IA, Lambert PA, Govan JR, Weller PH, Lacey DE, Allison DG, Giwercman B, Hoiby N.
    J Med Microbiol; 1998 Nov; 47(11):999-1006. PubMed ID: 9822299
    [Abstract] [Full Text] [Related]

  • 20. Molecular epidemiology of cystic fibrosis-linked Burkholderia cepacia complex isolates from three national referral centres in Ireland.
    Crowley D, Daly M, Lucey B, Shine P, Collins JJ, Cryan B, Moore JE, Murphy P, Buckley G, Fanning S.
    J Appl Microbiol; 2002 Nov; 92(5):992-1004. PubMed ID: 11972706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.